NP said 5 days ago that they have these negotiations for a licensing agreement, that there are other potential partners just in case, but that he hopes to resolve everything quickly. So the negotiations are still going on, in my opinion NP wants a little more for upfront payment, and the potential partner wants to see BLA to give more upfront, so in my opinion we are waiting for BLA. NP said that the data was sent to the FDA on November 22, if it is reasonable to expect the FDA to respond within 30 days then by December 22 they could receive a response with which dose we are going and then a licensing agreement could be finalized. In the next couple of weeks, everything came together, the end of the year and the possible sale of shares due to taxes, new shares came from warrants holders after 6 months, RP was selling intensively, but someone bought it all, the cancers results are excellent and the cancers program is progressing incredibly. The BLA is a turning point for me that CYDY can handle the financing and then the stock price will finally change direction after 5 years.